Summit Oncology
Summit Oncology Oncology Centers · Risk Stratification / Multimodal Fusion

Identify high-risk cases earlier in screening

Tumor board preparation time reduced by ~35%; high-risk cases reach specialist review sooner.

C-02-02

Customer background

Summit Oncology is a regional Oncology Center covering screening, staging discussions, and post-treatment follow-up. Outpatient and screening volume grows year over year, tumor board frequency is high, and the center needs to surface high-risk cases sooner and prepare consultations faster.

The center runs stable EHR / PACS environments, emphasizes on-premises deployment and auditable conclusions, and will not adopt AI through a rip-and-replace approach.

C-02-03

Challenges faced

Screening miss pressure

High-risk cohorts have long follow-up intervals; suspicious signals rarely enter a unified priority queue.

"Our biggest problem was that high-risk cases were often assembled the night before consultation."

Fragmented information

Imaging, pathology, and omics conclusions are scattered; tumor board preparation is time-consuming.

Conclusions hard to explain

Black-box scores cannot support QC, teaching, or external audit.

Cannot replace production systems

System replacement cost is high; sidecar integration and on-premises data are required.

C-02-04

Why Summit chose Neurovia

C-02-05

Implementation

From data checklist to tumor board preparation queue—on-premises pilot completed in ~8 weeks.

  1. Scope and data checklist

    Define screening / follow-up queues, success metrics, and interface inventory.

  2. On-premises deployment and integration

    Data center deployment, PACS sidecar integration, permissions and audit controls.

  3. Shadow run

    Parallel comparison with manual stratification; calibrate thresholds and override rules.

  4. Enter the standard clinical workflow

    High-risk cases automatically enter the tumor board preparation queue; QC spot checks begin.

Workstation during implementation
Implementation milestone · Risk Stratification workstation

C-02-06

Quantified outcomes

Typical pilot results (varies by data quality and workflow maturity).

Metric Pre-pilot Post-pilot Change
Tumor board preparation time index 100 65 −35%
High-risk specialist review timeliness Baseline Earlier +28%
QC-auditable case ratio 40% 90%+ Significant improvement

Where tumor board preparation time goes

Pre-pilot
Post-pilot
Data gathering Summary preparation Consultation coordination

Note: reductions come mainly from data gathering and summary preparation.

C-02-07

Customer quote

"Neurovia did not make us replace systems, yet high-risk cases are surfaced sooner. Last-minute case assembly before consultation is far less common, and QC finally has an audit trail."
Elena Vargas · Medical Director, Summit Oncology

Request a similar Oncology Centers pilot consultation

Receive a data checklist, success metrics, and 30-day pilot path.

Request a Demo All Case Studies